Tactiva Therapeutics Co-Founder Kunle Odunsi Elected to National Academy of Medicine Abstract BUFFALO, N.Y., October 16, 2018 -- Tactiva Therapeutics, a development stage company targeting a broad range of cancers, announced today that its co-founder Kunle Odunsi, M.D., Ph.D., FRCOG, FACOG, ... Read More
